20 /100
LOW RISK
Score updated May 30, 2026

ATOS — Atossa Therapeutics, Inc. Dilution Risk Tracker

Track ATOS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ATOS — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ATOS.
🔔 Track ATOS — Get forecast alerts →

💹 Market Data

Market Cap$45.04M
Shares Outstanding8.61M
Float8.58M
Cash$31.72M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 10.3% shares (2025Q4 vs prior)
67 institutional holders · 22.32M shares
#1 VANGUARD GROUP INC 6.15M shares
#2 AMERIPRISE FINANCIAL INC 3.79M shares
#3 RENAISSANCE TECHNOLOGIES LLC 2.06M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest341.3K
Days to Cover5.6
% of Float4.0%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2025
4 INSIDER TRANSACTION Mar 31, 2026
4 INSIDER TRANSACTION Mar 30, 2026
8-K 8K EVENT Feb 20, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track ATOS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ATOS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: A AAON ABLZF ACIW ADT
🔬 More Research for ATOS
📊 ATOS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ATOS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.